Overview
- 8 inspections across 8 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-09-12.
At a glance
Inspections
8
Sites
8
Observations
0
Career since
Apr 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biovectra Inc. | 12 Sep 2024 | Human Drugs | On file |
| Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company | 6 Jun 2024 | Human Drugs | On file |
| Amgen, Inc. | 6 Feb 2024 | Human Drugs | On file |
| Amgen Technology (Ireland) Unlimited Company | 16 Aug 2023 | Human Drugs | |
| PCI San Diego, Inc. | 9 Feb 2023 | Human Drugs | On file |
Sites inspected
Biovectra Inc.Windsor, Canada1 insp.
Bristol-Myers Squibb Holdings Pharma Ltd. Liability CompanyManati, United States1 insp.
Amgen, Inc.Thousand Oaks, United States1 insp.
Amgen Technology (Ireland) Unlimited CompanyDun Laoghaire, Ireland1 insp.
PCI San Diego, Inc.San Diego, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laurimer Kuilan-Torres2 shared
Zhong Li2 shared
Michal A Levine Millrod1 shared
Bo Chi1 shared
Song Y Lavalais1 shared
Wendy G Tan1 shared
Alan P Kurtzberg1 shared
Veronica Fuentes1 shared
Full investigator report
Get the verbatim findings behind Esther C Broner's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site